Literature DB >> 31808910

Sickle cell disease: a comprehensive program of care from birth.

Mariane de Montalembert1, Léon Tshilolo2, Slimane Allali1.   

Abstract

As more children are appropriately being diagnosed, the burden of sickle cell disease is increasing greatly in Africa and in high-resource countries such as the United States and Europe. Early management is mandatory, but newborn screening is not implemented everywhere. Point-of-care testing devices are increasingly being used in low-resource countries, showing good sensitivity and specificity. Because the diagnosis is often traumatic for the families, the announcement should be made by an experienced person. The development of care networks is urgently required to facilitate daily life by defining the respective functions of nearby and highly specialized health care professionals, who should work in close collaboration. Comprehensive programs targeting the prevention of pneumococcal infections, malaria in infested zones, and stroke may substantially improve patient care. Hydroxyurea is increasingly being used, but whether it should be systematically prescribed in all children is debated, and its access is still limited in many African countries. Yearly checkups should be organized early in life in order to screen and then treat any organ impairment. Enhancing parents' and patients' knowledge and skills is mandatory.
© 2019 by The American Society of Hematology. All rights reserved.

Entities:  

Year:  2019        PMID: 31808910      PMCID: PMC6913505          DOI: 10.1182/hematology.2019000053

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  40 in total

1.  Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa.

Authors:  Léon Tshilolo; George Tomlinson; Thomas N Williams; Brígida Santos; Peter Olupot-Olupot; Adam Lane; Banu Aygun; Susan E Stuber; Teresa S Latham; Patrick T McGann; Russell E Ware
Journal:  N Engl J Med       Date:  2018-12-01       Impact factor: 91.245

2.  Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes.

Authors:  Mariane de Montalembert; Valentine Brousse; Caroline Elie; Françoise Bernaudin; Junxin Shi; Paul Landais
Journal:  Haematologica       Date:  2006-01       Impact factor: 9.941

3.  Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment.

Authors:  Phu Quoc Lê; Béatrice Gulbis; Laurence Dedeken; Sophie Dupont; Anna Vanderfaeillie; Catherine Heijmans; Sophie Huybrechts; Christine Devalck; André Efira; Marie-Françoise Dresse; Laurence Rozen; Fleur Samantha Benghiat; Alina Ferster
Journal:  Pediatr Blood Cancer       Date:  2015-07-14       Impact factor: 3.167

4.  Posttraumatic stress disorder in children affected by sickle-cell disease and their parents.

Authors:  Michel Hofmann; Mariane de Montalembert; Bérengère Beauquier-Maccotta; Philippe de Villartay; Bernard Golse
Journal:  Am J Hematol       Date:  2007-02       Impact factor: 10.047

5.  Stroke Recurrence in Nigerian Children With Sickle Cell Disease: Evidence for a Secondary Stroke Prevention Trial.

Authors:  Shehu U Abdullahi; Michael R DeBaun; Lori C Jordan; Mark Rodeghier; Najibah A Galadanci
Journal:  Pediatr Neurol       Date:  2019-01-17       Impact factor: 3.372

6.  Invasive pneumococcal disease in children with sickle cell disease in the pneumococcal conjugate vaccine era.

Authors:  Olufunke O Martin; Kristin L Moquist; Jane M Hennessy; Stephen C Nelson
Journal:  Pediatr Blood Cancer       Date:  2017-07-04       Impact factor: 3.167

7.  Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.

Authors:  Cindy Steele; Annette Sinski; Jacqueline Asibey; Marie-Dominique Hardy-Dessources; Gisèle Elana; Colleen Brennan; Isaac Odame; Carolyn Hoppe; Mark Geisberg; Erik Serrao; Charles T Quinn
Journal:  Am J Hematol       Date:  2018-10-31       Impact factor: 10.047

8.  Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania.

Authors:  Julie Makani; Sharon E Cox; Deogratius Soka; Albert N Komba; Julie Oruo; Hadija Mwamtemi; Pius Magesa; Stella Rwezaula; Elineema Meda; Josephine Mgaya; Brett Lowe; David Muturi; David J Roberts; Thomas N Williams; Kisali Pallangyo; Jesse Kitundu; Gregory Fegan; Fenella J Kirkham; Kevin Marsh; Charles R Newton
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240

9.  Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions.

Authors:  Frédéric B Piel; Simon I Hay; Sunetra Gupta; David J Weatherall; Thomas N Williams
Journal:  PLoS Med       Date:  2013-07-16       Impact factor: 11.069

10.  Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.

Authors:  Russell E Ware; Barry R Davis; William H Schultz; R Clark Brown; Banu Aygun; Sharada Sarnaik; Isaac Odame; Beng Fuh; Alex George; William Owen; Lori Luchtman-Jones; Zora R Rogers; Lee Hilliard; Cynthia Gauger; Connie Piccone; Margaret T Lee; Janet L Kwiatkowski; Sherron Jackson; Scott T Miller; Carla Roberts; Matthew M Heeney; Theodosia A Kalfa; Stephen Nelson; Hamayun Imran; Kerri Nottage; Ofelia Alvarez; Melissa Rhodes; Alexis A Thompson; Jennifer A Rothman; Kathleen J Helton; Donna Roberts; Jamie Coleman; Melanie J Bonner; Abdullah Kutlar; Niren Patel; John Wood; Linda Piller; Peng Wei; Judy Luden; Nicole A Mortier; Susan E Stuber; Naomi L C Luban; Alan R Cohen; Sara Pressel; Robert J Adams
Journal:  Lancet       Date:  2015-12-06       Impact factor: 79.321

View more
  3 in total

1.  Clinical-Epidemiological Characteristics and Mortality in Patients with Sickle Cell Anemia: A Retrospective Cohort Study of 1980 at 2018.

Authors:  Carolina Mariano Pompeo; Marcos Antonio Ferreira Júnior; Andreia Insabralde de Queiroz Cardoso; Mercy da Costa Souza; Oleci Pereira Frota; Felipe Machado Mota; Maria Lúcia Ivo
Journal:  Int J Gen Med       Date:  2022-02-02

2.  Impact of COVID-19 pandemic on access to online therapeutic education programs for children with sickle cell disease.

Authors:  Alizee Sterlin; Mariane de Montalembert; Melissa Taylor; Sandrine Mensah; Marie Vandaele; Agathe Lanzeray; Louise Poiraud; Slimane Allali
Journal:  J Pediatr Nurs       Date:  2022-07-08       Impact factor: 2.523

Review 3.  Sickle Cell Disease in Children and Adolescents: A Review of the Historical, Clinical, and Public Health Perspective of Sub-Saharan Africa and Beyond.

Authors:  Walufu Ivan Egesa; Gloria Nakalema; William M Waibi; Munanura Turyasiima; Emmanuel Amuje; Gloria Kiconco; Simon Odoch; Patrick Kumbowi Kumbakulu; Said Abdirashid; Daniel Asiimwe
Journal:  Int J Pediatr       Date:  2022-10-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.